BSD Medical Corporation (BSDM)’s Investor and Analyst Conference Call Transcript

Clint Carnell – Chief Executive Officer

Thank you, Bill and thanks for your work, also wanna thank the employees the BSD medicals who have accepted me warmly and have really gone to work in a very passionate and committed manner. I recognize that you have been a long term shareholder at BSD that you are probably frustrated and we have some work to do to get things turned around. You have my commitment; my dedication and I believe we have something here that we can build a nice company around. I look forward to sharing our progress with you with the quarterly and yearly change of our fiscal year, will probably be made before our next earnings call, but I would like to plan on sharing with the investors as we understand more about how our programs are working so you can chart the progress and which is based on our turn around. So, with that Trish I will turn it back to you and thank you every one.38:25

Operator

For the Q & A sessions for analysts, to ask a question press star then 1 on the phone . If you’re using speaker phones please pick your handset before pressing the key. If any of your questions has been addressed and you’ll like to draw your question please press star then 2. Again a star then, 1 to ask a question. At the time we’ll just pause momentarily . Now we have a question from Dan Akovich from Maxim group. Please go ahead.

Dan Yankovich – Maxim Group

Hey Clint Congrats! Good to hear your voice again. Had a couple of quick questions and might have missed this or you might have said that you’re not discussing this right now but for the you guys coming out or fresh coming out with new micro.. microwave tips. Any indication on what potential differences you guys are targeting?

Clint Carnell – Chief Executive Officer

Yeah Daniel, I’ll speak in generality, first thanks for joining the call for the question. If you’re aware of the synchronous wave alignment technology one of the advantages we have with 915 is that we can go in and treat very delicate organs, say lungs, where there have been some complications with more powerful modalities. And we can allow to position the flexibility of multiple antennas to deliver enough energy to ablate the tumor while not compromising safety for the patient. Positions have asked us for new tips, primarily for a couple of reasons. One is to smaller ablation areas and also to do potentially more ablations with fewer antennas. So, I think what we wanna do is provide to position the tools to go when based upon their diagnosis. And provide more versatility than we do at this point. We think that is a significant advantage over some of the current technologies in the marketplace.